Mojdeh Poul serves as President, Chief Executive Officer, and Director of Integra LifeSciences Holdings Corporation, a global leader in surgical implants, regenerative technologies, and neurosurgical products. Appointed CEO in May 2024, she brings over 25 years of executive experience in the medical technology industry, with a proven track record of driving commercial growth, innovation, and operational excellence. Under her leadership, Integra continues to advance its mission of improving patient outcomes through cutting-edge solutions in tissue technologies, orthopedics, and spine products. Poul joined Integra in 2021 as President of Global Products & Solutions, where she oversaw the company's product portfolio and commercial operations. Prior to Integra, she spent 15 years at Medtronic, rising to President of the Cranial & Spinal Technologies Operating Unit, managing a $1.2 billion business focused on neurosurgery and neuromodulation. Her earlier career included key roles at Johnson & Johnson, including Vice President of Marketing and Strategy for Biosense Webster, honing her expertise in global market expansion and product commercialization. Throughout her career, Poul has spearheaded transformative initiatives, including the launch of groundbreaking neurostimulation devices and the integration of digital health technologies, resulting in double-digit revenue growth and market share gains. A chemical engineer by training with an MBA from UCLA Anderson School of Management, she is recognized for her strategic vision and commitment to diversity and inclusion in medtech, positioning Integra for sustained leadership in regenerative medicine.